Related Experiment Video

Updated: Jun 5, 2026

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
08:23

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

The child with glutaric aciduria type I: anesthetic and perioperative management

Adelais G Tsiotou1, Anna Malisiova, Nikolaos Bouzelos

  • 1Anesthesiology Department, Children's Hospital P. & A. Kyriakou, Arkadias 19-21, 115 26 Athens, Greece. adeltsiotou@yahoo.gr

Journal of Anesthesia
|January 12, 2011
PubMed

Insights

Glutaric aciduria type I (GA-1), a metabolic disorder, requires careful perioperative management for surgical patients. This case study details anesthetic and postoperative strategies for a child undergoing hip dislocation surgery.

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Pediatric Anesthesiology

Background:

  • Glutaric aciduria type I (GA-1) is an inherited metabolic disorder affecting glutaryl-CoA dehydrogenase.
  • GA-1 can lead to severe neurologic damage, particularly after metabolic stress.
  • Children with GA-1 require specialized care during surgical procedures.

Observation:

  • A 5-year-old boy with GA-1 presented for surgery due to neurogenic hip dislocation.
  • The patient required meticulous preoperative preparation, including fluid management and intensified therapy.
  • Anesthesia was safely managed using inhalation agents and remifentanil, considering the disease's mitochondrial implications.

Findings:

  • Successful perioperative management was achieved through tailored fluid administration and therapy.
  • Inhalation anesthesia combined with remifentanil provided a safe anesthetic course.
  • Postoperative care focused on preventing stress responses and managing GA-1-related complications.

Implications:

  • This case highlights the importance of individualized perioperative protocols for GA-1 patients.
  • Effective management can mitigate risks associated with anesthesia and surgery in these children.
  • Optimized care strategies are crucial for preventing metabolic decompensation and neurologic sequelae.

More Related Videos

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...